home / stock / nlspw / nlspw quote
Last: | $0.0497 |
---|---|
Change Percent: | -76.09% |
Open: | $0.0523 |
Close: | $0.0497 |
High: | $0.06 |
Low: | $0.015 |
Volume: | 48,286 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0497 | $0.0523 | $0.0497 | $0.06 | $0.015 | 48,286 | 07-05-2024 |
$0.0297 | $0.0495 | $0.0297 | $0.0572 | $0.0297 | 40,759 | 07-04-2024 |
$0.0297 | $0.0495 | $0.0297 | $0.0572 | $0.0297 | 40,759 | 07-03-2024 |
$0.031 | $0.0302 | $0.031 | $0.0378 | $0.0211 | 13,225 | 07-02-2024 |
$0.0381 | $0.0301 | $0.0381 | $0.0381 | $0.0301 | 4,700 | 07-01-2024 |
$0.034549 | $0.06 | $0.034549 | $0.06 | $0.03 | 38,994 | 06-28-2024 |
$0.0311 | $0.04 | $0.0311 | $0.0595 | $0.0302 | 54,027 | 06-27-2024 |
$0.0399 | $0 | $0.0399 | $0 | $0 | 85 | 06-25-2024 |
$0.0399 | $0.0315 | $0.0399 | $0.04 | $0.026 | 2,761 | 06-24-2024 |
$0.0311 | $0.04 | $0.0311 | $0.04 | $0.0311 | 10,047 | 06-21-2024 |
$0.0312 | $0.039199 | $0.0312 | $0.039199 | $0.03 | 8,448 | 06-20-2024 |
$0.0381 | $0.0479 | $0.0381 | $0.0598 | $0.0381 | 115,329 | 06-19-2024 |
$0.0381 | $0.0479 | $0.0381 | $0.0598 | $0.0381 | 115,329 | 06-18-2024 |
$0.0375 | $0.0375 | $0.0375 | $0.0375 | $0.0375 | 1,340 | 06-17-2024 |
$0.029723 | $0.026 | $0.029723 | $0.029723 | $0.026 | 1,700 | 06-14-2024 |
$0.026 | $0.03 | $0.026 | $0.045 | $0.026 | 25,931 | 06-13-2024 |
$0.0409 | $0.028 | $0.0409 | $0.0409 | $0.023 | 37,244 | 06-12-2024 |
$0.0221 | $0.0232 | $0.0221 | $0.033 | $0.0221 | 6,009 | 06-11-2024 |
$0.02201 | $0.02201 | $0.02201 | $0.02201 | $0.02201 | 126 | 06-10-2024 |
$0.029351 | $0.028 | $0.029351 | $0.0378 | $0.0201 | 10,732 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
NLS Pharmaceutics Ltd. Warrant Company Name:
NLSPW Stock Symbol:
NASDAQ Market:
NLS Pharmaceutics Ltd. Warrant Website:
ZURICH, SWITZERLAND / ACCESSWIRE / June 28, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sys...
ZURICH, SWITZERLAND / ACCESSWIRE / June 27, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, today announced preclinical re...
ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a leading Swiss biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, announced today that it received noti...